Vitamin K Market Market Size

Vitamin K Market size was valued at USD 919.7 million in 2023 and is predicted to reach USD 2.53 billion by the end of 2036, registering around 8.8% CAGR during the forecast period i.e., between 2024-2036. In 2024, the industry size of vitamin K is estimated at USD 1 billion.

Factors such as rapidly increasing cases of postmenopausal osteoporosis, cardiovascular disease, and an increase in the global geriatric population facing vitamin deficiencies are attributed to drive the vitamin K market expansion. Furthermore, the increasing need for vitamin K1 injectables to save infants from any complexities, and growing demand for nutritional food & drinks to maintain the growth and metabolism in children is propelling the market growth. For instance, in November 2023 Abbott announced the launch of PediaSure with Nutri-Pull system to support children’s growth and development. The Nutri-Pull is a unique combination of ingredients like vitamin K2, vitamin D, vitamin C, and casein phosphopeptides (CPPs), which help support growth amongst children through the absorption of key nutrients.

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of vitamin K was valued at USD 919.7 million.

The market size for vitamin K is projected to be valued at USD 2530.4 million by the end of 2036 expanding at a CAGR of 8.8% during the forecast period i.e., between 2024â€“2036.

The major players in the market are Glanbia Plc, Farbest Brands, Adisseo, Lonza Group, Smidge Small Batch Supplements, SternVitamin GmbH & Co. K.G., DSM, Livealth Biopharma, Pfizer Inc., Solgar Inc., NOW Foods, Rabar Pty Ltd, and others.

The North America vitamin K sector is poised to register 42.0 % share by the end of 2036.

Vitamin K Market Market Size